CytomX and MD Anderson Cancer Center enter into strategic collaboration for…
CytomX Therapeutics (Nasdaq: CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today entered into a collaboration with The University of...














